Search Options Stock News and Analysis from Schaeffer's

https://www.schaeffersresearch.com/content/news/2018/10/01/3-drug-stocks-getting-crushed

10/1/2018 2:04 PM

U.S. stocks are off to a strong start to the fourth quarter, with the Dow getting a lift today thanks to the trade agreement with Canada. Meanwhile, we're monitoring big moves out of the healthcare s...

Call Options Hot as Akorn Stock Nears Bottom of Nasdaq

https://www.schaeffersresearch.com/content/options/2018/08/23/call-options-hot-as-akorn-stock-nears-bottom-of-nasdaq

8/23/2018 2:51 PM

The shares of Akorn, Inc. (NASDAQ:AKRX) are trading near the bottom of the Nasdaq today -- down 21.7% at $13.96 -- after the judge ruling on the generic pharmaceutical firm's legal dispute against Fr...

3 Drug Stocks Near the Bottom of the Nasdaq Today

https://www.schaeffersresearch.com/content/news/2018/05/02/3-drug-stocks-near-the-bottom-of-the-nasdaq-today

5/2/2018 3:22 PM

The Nasdaq is outperforming today, thanks to a positive earnings reaction for Apple (AAPL). Nevertheless, drug stocks Akorn, Inc. (NASDAQ:AKRX), Esperion Therapeutics Inc (NASDAQ:ESPR), and Gilead Sc...

Dow, S&P Lower on Fed Anticipation

https://www.schaeffersresearch.com/content/ezines/2018/05/02/dow-s-p-lower-on-fed-anticipation

5/2/2018 12:03 PM

Building anticipation ahead of this afternoon's Fed policy decision is overshadowing an Apple (AAPL) earnings beat, with the Dow Jones Industrial Average (DJI) and S&P 500 Index (SPX) lower at m...

Akorn Put Buyers Cheer as Stock Rocked By Abandoned Takeover

https://www.schaeffersresearch.com/content/news/2018/04/23/akorn-put-buyers-cheer-as-stock-rocked-by-abandoned-takeover

4/23/2018 9:58 AM

Akorn, Inc. (NASDAQ:AKRX) stock is down 35% to trade at $12.79, and fresh off a new five-year low of $12.40. AKRX stock is among the worst on the Nasdaq so far today, after Germany's Fresenius pulled...

PEOPLE ALSO SEARCH FOR